レポートナンバー 0000032420
22カ国におけるラテンアメリカの癌診断市場データベース（2022年〜2026年）- 試薬・機器サプライヤーの売上高と市場シェア、主要な腫瘍マーカーの数量・売上高セグメントの予測
VPGMarketResearch
2022-2026 Latin America Cancer Diagnostics Market Database for 22 Countries--Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
発刊日
2022/06/08
言語英語
体裁PDF
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
レポート概要
この22カ国におけるデータベースは、ラテンアメリカにおける2021年のサプライヤーシェアや2021年から2026年の主要な腫瘍マーカーの数量と売上予測など、他の公開されたソースからは入手できない情報と分析を提供します。また、新技術を開発または販売している企業の包括的なリストを以下の検査別に提供します。
本レポートはセクションごとに用意されており、特定の情報ニーズや予算に応じてカスタマイズすることができます。
-
検査別
ACTH、AFP、β2ミクログロブリン、CA15-3/27. 29、CA 19-9、CA 125、カルシトニン、カテプシン、CEA、クロモグラニン、結腸特異抗原、サイトケラチン、エストロゲンレセプター、フェリチン、ガストリン、HCG、インスリン、インターフェロン、インターロイキン、リンパ球サブタイプ、ニューロン特異エノラーゼ、核仁、潜血、癌遺伝子、膵臓癌胎児性抗原、パップスメア、副甲状腺ホルモン、プロゲステロン、膵癌性抗腫瘍因子（PGN) 膵臓癌胎児性抗原、パップスメア、副甲状腺ホルモン、プロゲステロン受容体、前立腺酸性フォスファターゼ、前立腺特異抗原、S-100タンパク質、セロトニン、シアル酸、扁平上皮癌抗原、TDT、チミジンキナーゼ、サイログロブリン、組織ポリペプチド抗原、およびその他
-
調査国
アルゼンチン、ボリビア、ブラジル、チリ、コロンビア、コスタリカ、キューバ、ドミニカ共和国、エクアドル、エルサルバドル、グアテマラ、ハイチ、ホンジュラス、ジャマイカ、メキシコ、ニカラグア、パナマ、パラグアイ、ペルー、プエルトリコ、ウルグアイ、ベネズエラ
レポート詳細
目次
List of Tables
Argentina Cancer Diagnostic Volume Forecasts by Test
Argentina Cancer Diagnostics Sales Forecasts by Test
Bolivia Cancer Diagnostic Volume Forecasts by Test
Bolivia Cancer Diagnostics Sales Forecasts by Test
Brazil Cancer Diagnostic Volume Forecasts by Test
Brazil Cancer Diagnostics Sales Forecasts by Test
Chile Cancer Diagnostic Volume Forecasts by Test
Chile Cancer Diagnostics Sales Forecasts by Test
Colombia Cancer Diagnostic Volume Forecasts by Test
Colombia Cancer Diagnostics Sales Forecasts by Test
Costa Rica Cancer Diagnostic Volume Forecasts by TestCosta Rica Cancer Diagnostics Sales Forecasts by Test
Cuba Cancer Diagnostic Volume Forecasts by Test
Cuba Cancer Diagnostics Sales Forecasts by Test
Dominican Republic Cancer Diagnostic Volume Forecasts by Test
Dominican Republic Cancer Diagnostics Sales Forecasts by Test
Ecuador Cancer Diagnostic Volume Forecasts by Test
Ecuador Cancer Diagnostics Sales Forecasts by Test
El Salvador Cancer Diagnostic Volume Forecasts by Test
El Salvador Cancer Diagnostics Sales Forecasts by Test
Guatemala Cancer Diagnostic Volume Forecasts by Test
Guatemala Cancer Diagnostics Sales Forecasts by Test
Haiti Cancer Diagnostic Volume Forecasts by Test
Haiti Cancer Diagnostics Sales Forecasts by Test
Honduras Cancer Diagnostic Volume Forecasts by Test
Honduras Cancer Diagnostics Sales Forecasts by Test
Jamaica Cancer Diagnostic Volume Forecasts by Test
Jamaica Cancer Diagnostics Sales Forecasts by Test
Mexico Cancer Diagnostic Volume Forecasts by Test
Mexico Cancer Diagnostics Sales Forecasts by Test
Nicaragua Cancer Diagnostic Volume Forecasts by Test
Nicaragua Cancer Diagnostics Sales Forecasts by Test
Panama Cancer Diagnostic Volume Forecasts by TestPanama Cancer Diagnostics Sales Forecasts by Test
Paraguay Cancer Diagnostic Volume Forecasts by Test
Paraguay Cancer Diagnostics Sales Forecasts by Test
Peru Cancer Diagnostic Volume Forecasts by Test
Peru Cancer Diagnostics Sales Forecasts by Test
Puerto Rico Cancer Diagnostic Volume Forecasts by Test
Puerto Rico Cancer Diagnostics Sales Forecasts by Test
Uruguay Cancer Diagnostic Volume Forecasts by Test
Uruguay Cancer Diagnostics Sales Forecasts by Test
Venezuela Cancer Diagnostic Volume Forecasts by Test
Venezuela Cancer Diagnostics Sales Forecasts by Test
Tumor Marker Classification
Major Companies Developing or
Marketing ACTH Tests
Major Companies Developing or
Marketing AFP Tests
Major Companies Developing or
Marketing Beta-2 Microglobulin Tests
Major Companies Developing or
Marketing CA 15-3/27.29 Tests
Major Companies Developing or
Marketing CA 19-9 Tests
Major Companies Developing or
Marketing CA 125 Tests
Major Companies Developing or
Marketing Calcitonin Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Estrogen Receptor Tests
Major Companies Developing or
Marketing Progesterone Receptor Tests
Major Companies Developing or
Marketing Ferritin Tests
Major Companies Developing or
Marketing Gastrin Tests
Major Companies Developing or
Marketing HCG Tests
Major Companies Developing or
Marketing Insulin Tests
Major Companies Developing or
Marketing NSE Tests
Major Companies Developing or
Marketing Occult Blood Tests
Major Companies Developing or
Marketing PAP Smear/HPV Tests
Major Companies Developing or
Marketing PAP Tests
Major Companies Developing or
Marketing PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or
Marketing Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
in Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
